WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Patrick D. WalshDirector2026-05-1310,000$80.63
$806.30kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2026-05-13500$78.16
$39.08kSell
Thomas Andrew RowlandSVP HEAD - ESTABLISHED BRANDS2026-05-12459$79.21
$36.36kSell
Ori GutwergSVP GENERICS2026-05-122,772$79.50
$220.37kSell
Nikhil LalwaniPRESIDENT CEO2026-05-1155,000$77.57
$4.27MSell
Patrick D. WalshDirector2026-05-113,973$80.75
$320.82kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2026-04-13500$77.95
$38.98kSell
Meredith CookSR. VP GENERAL COUNSEL SEC.2026-03-13500$72.62
$36.31kSell
Christopher MutzHEAD OF RARE DISEASE2026-03-133,162$71.64
$226.53kSell
Thomas Andrew RowlandSVP HEAD - ESTABLISHED BRANDS2026-03-114,772$74.91
$357.47kSell

1 of 11

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP82.38%18,737,728$1.49BInsider
Robert E. Brown Jr.74.60%16,967,490$1.35BInsider
Ross J. Mangano25.46%5,792,084$459.54MInsider
Blackrock Inc12.08%2,747,492$217.99MInstitution
Tracy Marshbanks10.15%2,308,568$183.16MInsider
Victor A. Morgenstern4.12%936,014$74.26MInsider
Vanguard Capital Management LLC3.62%823,064$65.30MInstitution
Soleus Capital Management LP3.61%820,243$65.08MInstitution
State Street Corp3.39%771,587$61.22MInstitution
Tang Capital Management LLC3.11%707,500$56.13MInstitution

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP32.72%67.28%Net SellingNet Buying
BHC49.65%50.35%Net BuyingNet Selling
HCM0.49%0.06%
PRGO64.95%35.05%Net BuyingNet Buying
PBH69.12%30.88%Net SellingNet Selling
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 102.45% institutional shareholders, 210.69% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 82.38% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.51B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.